acetylglucosamine has been researched along with Neoplasms in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.82) | 18.7374 |
1990's | 3 (4.23) | 18.2507 |
2000's | 10 (14.08) | 29.6817 |
2010's | 41 (57.75) | 24.3611 |
2020's | 15 (21.13) | 2.80 |
Authors | Studies |
---|---|
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Ciraku, L; Esquea, EM; Reginato, MJ | 1 |
Chen, YF; Li, J; Ye, XS; Zhu, JJ | 1 |
Lim, TK; Lin, Q; Shen, HM; Wang, J; Wong, YK; Yap, CT | 1 |
Cao, M; Chin, AR; Duggan, E; Esko, JD; Ghassemian, M; Jiang, L; Lee, S; Lemanek, A; Nolan, JP; Pizzo, DP; Qiao, Y; Ruan, X; Schenk, S; Wan, Y; Wang, D; Wang, SE; Yan, W | 1 |
Chen, WR; DeVette, CI; Hildebrand, WH; Hode, T; Hoover, AR; Krawic, JR; Lam, SSK; Liu, K; Medcalf, AD; Sun, XH; Welm, AL; West, CL | 1 |
Cui, M; Liao, Q; Liu, Q; Yang, S | 1 |
Bai, X; Liang, T; Lu, Q; Zhang, X | 1 |
Itano, N; Iwamoto, S | 1 |
Chu, F; Fang, X; Tian, Z; Wang, B; Wang, S; Wang, Y; Zhang, L; Zhou, F | 1 |
de-Freitas-Junior, JCM; de-Souza-Ferreira, M; Ferreira, ÉE | 1 |
Le Minh, G; Reginato, MJ | 1 |
He, XF; Hu, X; Lin, WJ; Wang, Z; Wen, GJ | 1 |
Esquea, EM; Huang, J; Le Minh, G; Reginato, MJ; Young, RG | 1 |
Ding, Z; Han, W; Han, X; Herzog, RI; Jiang, M; Kaech, S; Lee, JS; Lee, P; Li, MD; Ni, W; Nie, Y; Ong, Q; Qian, K; Ruan, HB; Sherwin, RS; Singh, JP; Singh, K; Wendel, HG; Wu, J; Yang, X; Yates, JR; Zhang, B; Zhang, K; Zhou, J | 1 |
Chen, WR; Hode, T; Korbelik, M; Lam, SSK | 1 |
Dall'Olio, F; Trinchera, M | 1 |
Cai, Y; Jin, J; Wu, D | 1 |
Mahajan, K; Pawar, S; Vavia, P | 1 |
Bourakba, M; Pieters, RJ; Ruijtenbeek, R; Sharif, S; Shi, J | 1 |
Aguilar, AL; Hou, X; Wang, PG; Wen, L; Wu, P | 1 |
Hagan, CR; Trinca, GM | 1 |
da Costa Rodrigues, B; de Queiroz, RM; Dias, WB; Todeschini, AR; Vasconcelos-Dos-Santos, A | 1 |
Ahmed, NH; Baruah, FK; Grover, RK | 1 |
Bond, MR; Chen, W; Hanover, JA | 1 |
Alam, MM; Igarashi, K; Kato, K; Katsuoka, F; Kobayashi, A; Motohashi, H; Okazaki, K; Sekine, H; Shima, H; Suzuki, N; Tsujita, T; Yamamoto, M | 1 |
Lam, C; Phillips, RM; Tran, PT; Wang, H | 1 |
Dukie, SA; Makwana, V; Patel, B; Rudrawar, S; Ryan, P | 1 |
Nie, H; Yi, W | 1 |
He, J; Huang, Y; Li, Y; Liu, J; Luo, Y; Wang, H; Zhao, Y; Zhong, L | 1 |
Koide, R; Nishimura, SI | 1 |
Bond, MR; Hanover, JA | 1 |
Ma, Z; Vosseller, K | 2 |
Li, Z; Yi, W | 1 |
Singh, JP; Wu, J; Yang, X; Zhang, K | 1 |
Ferrer, CM; Reginato, MJ | 1 |
Hardivillé, S; Hart, GW | 1 |
Bryś, M; Forma, E; Jóźwiak, P; Krześlak, A | 1 |
Nordgren, KK; Skildum, AJ | 1 |
Ball, LE; Nagel, AK | 1 |
Audfray, A; Beldjoudi, M; Boos, I; Bouras, M; Breiman, A; Busser, B; Coll, JL; Hurbin, A; Imberty, A; Lantuejoul, S; Le Pendu, J; Unverzagt, C; Varrot, A | 1 |
Hanover, JA; Olivier-Van Stichelen, S | 1 |
Efimova, EV; Kozmin, SA; Kron, SJ; Labay, E; Shamsi, NA; Takahashi, S; Ulanovskaya, OA; Weichselbaum, RR; Wu, D | 1 |
Akinkuolie, AO; Buring, JE; Chandler, PD; Glynn, RJ; Lawler, PR; Lee, IM; Moorthy, MV; Mora, S; Ridker, PM; Schaumberg, DA; Vandenburgh, MJ | 1 |
Banerjee, PS; Hart, GW; Lagerlöf, O | 1 |
Tuorkey, MJ | 1 |
Navon, G; Rivlin, M | 1 |
Angström, J; Blomqvist, M; Carpén, O; Haglund, C; Heiskanen, A; Leonardsson, I; Natunen, J; Olonen, A; Saarinen, J; Salovuori, N; Satomaa, T; Teneberg, S | 1 |
Cho, JW; Jang, I; Ji, S; Kang, JG; Kim, HS; Kim, SM; Park, S; Park, SY; Park, YI; Roth, J; Yook, JI | 1 |
Copeland, RJ; Hart, GW; Slawson, C | 1 |
Fukuda, T; Gu, J; Isaji, T; Kariya, Y; Taniguchi, N; Xu, Q | 1 |
Grande, S; Guidoni, L; Luciani, AM; Palma, A; Rosi, A; Viti, V | 1 |
Hart, GW; Lagerlof, O; Ramirez-Correa, G; Slawson, C | 1 |
Hart, GW; Slawson, C | 2 |
Alvarez, R; Cummings, RD; Miwa, HE; Song, Y; Stanley, P | 1 |
Clark, PM; Driggers, EM; Goddard, WA; Hill, C; Hsieh-Wilson, LC; Keenan, MC; Mason, DE; Peters, EC; Yi, W | 1 |
Hyttinen, JM; Jokela, TA; Kärnä, R; Oikari, S; Rilla, K; Tammi, MI; Tammi, RH | 1 |
SILBERT, JE | 1 |
Chou, TY; Hart, GW | 1 |
Honda, T; Ishii, K; Nakajima, K; Nakayama, J; Ota, H; Sano, K; Zhang, MX | 1 |
Deltour, S; Guérardel, C; Lefebvre, T; Leprince, D; Martin-Soudant, N; Michalski, JC; Pinte, S; Slomianny, MC | 1 |
Arvanitis, DL; Arvanitis, LD; Kanavaros, P; Kitsoulis, P; Panourias, IG | 1 |
Kamboj, SS; Kaur, A; Pandita, RM; Sexana, AK; Shamnugavel, M; Singh, J | 1 |
Bezouska, K; Budka, J; Dudic, M; Fiserová, A; Hulíková, K; Kren, V; Krenek, K; Kuldová, M; Lhoták, P; Pelantová, H; Stibor, I | 1 |
Renkonen, O; Saksela, E; Seppo, A; Yagita, M | 1 |
Baccino, FM; Hasilik, A; Isidoro, C | 1 |
Amiji, M; Nsereko, S | 1 |
Confort-Gouny, S; Cozzone, PJ; Fayre, R; Fontanarava, E; Harlé, JR; Kriat, M; Maraninchi, D; Sciaky, M; Vion-Dury, J; Viout, P | 1 |
Ogawara, M; Sone, S; Utsugi, T; Yamazaki, M | 1 |
38 review(s) available for acetylglucosamine and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
O-GlcNAcylation regulation of cellular signaling in cancer.
Topics: Acetylglucosamine; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Phosphorylation; Protein Processing, Post-Translational | 2022 |
Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications.
Topics: Acetylglucosamine; Fucose; Galactose; Glycosylation; Humans; Immunoglobulin G; N-Acetylneuraminic Acid; Neoplasms | 2022 |
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
Topics: Acetylglucosamine; Animals; Diabetes Mellitus; Humans; Neoplasms; Neovascularization, Pathologic; Protein Processing, Post-Translational; Proteins | 2022 |
Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Topics: Acetylglucosamine; Biological Phenomena; Biosynthetic Pathways; Hexosamines; Humans; Neoplasms; Uridine Diphosphate | 2023 |
The role of O-GlcNAcylation in innate immunity and inflammation.
Topics: Acetylglucosamine; Humans; Immunity, Innate; Inflammation; Neoplasms; Phosphorylation; Protein Processing, Post-Translational | 2023 |
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
Topics: Acetylglucosamine; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Phenotype; Polysaccharides | 2023 |
Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
Topics: Acetylglucosamine; Cell Plasticity; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Nutrients; Protein Processing, Post-Translational; Tumor Microenvironment; Uridine Diphosphate | 2023 |
O-GlcNAcylation in cancer development and immunotherapy.
Topics: Acetylglucosamine; Humans; Immunotherapy; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational; Proteins; Signal Transduction | 2023 |
On a sugar high: Role of O-GlcNAcylation in cancer.
Topics: Acetylglucosamine; Biosynthetic Pathways; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational | 2023 |
Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy.
Topics: Acetylglucosamine; Adjuvants, Immunologic; Animals; Humans; Immunity; Neoplasms; Photochemotherapy; Treatment Outcome | 2021 |
Epigenetic Bases of Aberrant Glycosylation in Cancer.
Topics: Acetylglucosamine; Animals; Epigenesis, Genetic; Galectins; Glycosylation; Histones; Humans; Neoplasms; Protein Processing, Post-Translational | 2017 |
Potential coordination role between O-GlcNAcylation and epigenetics.
Topics: Acetylglucosamine; Animals; Epigenesis, Genetic; Glycoside Hydrolases; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational | 2017 |
O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.
Topics: Acetylglucosamine; Breast Neoplasms; Carcinogenesis; Endometrial Neoplasms; Female; Glycosylation; Humans; Neoplasms; Ovarian Neoplasms; Protein Processing, Post-Translational | 2018 |
Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.
Topics: Acetylglucosamine; Animals; Disease Progression; Glycosylation; Humans; Hyperglycemia; Neoplasms | 2018 |
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Topics: Acetylglucosamine; Animals; Biosynthetic Pathways; Glycosylation; Humans; Neoplasms | 2018 |
Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Topics: Acetylglucosamine; Biosynthetic Pathways; Cell Transformation, Neoplastic; Disease Progression; Epithelial-Mesenchymal Transition; Glycosylation; Hexosamines; Humans; Neoplasms | 2019 |
Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
Topics: Acetylglucosamine; beta Catenin; Enzyme Inhibitors; Glycosylation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Oncogenes; Sterol Regulatory Element Binding Proteins | 2019 |
O-GlcNAcylation, a sweet link to the pathology of diseases.
Topics: Acetylglucosamine; Animals; Apoptosis; beta-N-Acetylhexosaminidases; Cardiovascular Diseases; Catalysis; Cell Nucleus; Cell Proliferation; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Type 2; Hexosamines; Humans; Insulin; Mitochondria; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction | 2019 |
O-GlcNAc cycling: a link between metabolism and chronic disease.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Diabetes Mellitus, Type 2; Diet; Energy Metabolism; Gene Expression Regulation; Health Status; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Protein Stability; Uridine Diphosphate N-Acetylglucosamine | 2013 |
O-GlcNAc in cancer biology.
Topics: Acetylglucosamine; Animals; Humans; Neoplasms | 2013 |
Regulation of cancer metabolism by O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Enzymes; Humans; Neoplasms; NF-kappa B; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-myc; Transcription Factors; Tumor Suppressor Protein p53 | 2014 |
O-GlcNAc signaling in cancer metabolism and epigenetics.
Topics: Acetylglucosamine; Antigens, Neoplasm; Cell Proliferation; Energy Metabolism; Epigenesis, Genetic; Glycosylation; Histone Acetyltransferases; Histones; Humans; Hyaluronoglucosaminidase; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational; Serine; Signal Transduction; Threonine; Transcription Factors; Transcription, Genetic; Transcriptional Activation | 2015 |
Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation.
Topics: Acetylglucosamine; AMP-Activated Protein Kinases; Diabetes Mellitus; Epigenomics; Glycosylation; Humans; Neoplasms; Signal Transduction; Transcription, Genetic | 2014 |
The potential role of O-GlcNAc modification in cancer epigenetics.
Topics: Acetylglucosamine; Acylation; Animals; beta-N-Acetylhexosaminidases; Epigenesis, Genetic; Histones; Humans; Models, Genetic; N-Acetylglucosaminyltransferases; Neoplasms | 2014 |
Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Topics: Acetylglucosamine; Animals; Carcinogenesis; Epigenesis, Genetic; Humans; Neoplasms; Neovascularization, Pathologic; Signal Transduction | 2014 |
The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer.
Topics: Acetylation; Acetylglucosamine; Citric Acid Cycle; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glycosylation; Histones; Humans; Methylation; Neoplasms; S-Adenosylmethionine; Uridine Diphosphate | 2015 |
Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Topics: Acetylglucosamine; Animals; Epigenomics; Food; Glycosylation; Humans; Metabolic Networks and Pathways; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational | 2015 |
You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.
Topics: Acetylglucosamine; Alzheimer Disease; Cardiovascular Diseases; Chromatin; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Feeding Behavior; Female; Gene Expression Regulation; Genetic Loci; Genomic Imprinting; Homeostasis; Humans; Hypothalamo-Hypophyseal System; Lupus Erythematosus, Systemic; N-Acetylglucosaminyltransferases; Neoplasms; Neurogenesis; Obesity; Protein Processing, Post-Translational; X Chromosome Inactivation | 2015 |
Roles of O-GlcNAc in chronic diseases of aging.
Topics: Acetylglucosamine; Aging; Chronic Disease; Diabetes Mellitus; Heart Diseases; Humans; Hyperglycemia; Inflammation; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases | 2016 |
F2 Gel Matrix a Novel Delivery System for Immune and Gene Vaccinations.
Topics: Acetylglucosamine; Animals; Gene Transfer Techniques; Genetic Vectors; Humans; Microalgae; Neoplasms; Polymers; Transfection; Vaccination; Vaccines, DNA | 2016 |
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Topics: Acetylglucosamine; Animals; Diabetes Mellitus; Hexosamines; Humans; Insulin; Neoplasms; Signal Transduction | 2010 |
Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
Topics: Acetylglucosamine; Animals; Carbohydrate Sequence; Cell Adhesion; Cell Physiological Phenomena; Genetic Techniques; Glycosylation; Humans; Integrins; Models, Biological; N-Acetylglucosaminyltransferases; Neoplasms | 2010 |
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
Topics: Acetylglucosamine; Animals; Chronic Disease; Diabetes Mellitus; Glycosylation; Humans; Models, Molecular; Molecular Structure; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Conformation; Signal Transduction; Transcription, Genetic | 2011 |
O-GlcNAc signalling: implications for cancer cell biology.
Topics: Acetylglucosamine; Acylation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; N-Acetylglucosaminyltransferases; Neoplasms; Signal Transduction; Substrate Specificity | 2011 |
The bisecting GlcNAc in cell growth control and tumor progression.
Topics: Acetylglucosamine; Animals; Cell Proliferation; Disease Progression; Galectins; Humans; Intercellular Signaling Peptides and Proteins; N-Acetylglucosaminyltransferases; Neoplasms; Signal Transduction | 2012 |
O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc.
Topics: Acetylglucosamine; Animals; Binding Sites; Glycoconjugates; Glycosylation; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-myc | 2001 |
Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation.
Topics: Acetylglucosamine; Animals; Homeostasis; Humans; Neoplasms; Phosphates; Protein Biosynthesis; Proteins; Signal Transduction; Transcription, Genetic | 2003 |
33 other study(ies) available for acetylglucosamine and Neoplasms
Article | Year |
---|---|
O-GlcNAcylation increases PYGL activity by promoting phosphorylation.
Topics: Acetylglucosamine; Glucose; Glycogen; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Phosphorylation; Protein Processing, Post-Translational | 2022 |
O-GlcNAcylation promotes fatty acid synthase activity under nutritional stress as a pro-survival mechanism in cancer cells.
Topics: Acetylglucosamine; Fatty Acid Synthases; Fatty Acids; HeLa Cells; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational; Proteins | 2022 |
Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis.
Topics: Acetylglucosamine; Animals; Humans; Mice; MicroRNAs; Muscle, Skeletal; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational; Proteolysis; Ryanodine Receptor Calcium Release Channel | 2022 |
Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.
Topics: Acetylglucosamine; Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; Mice; Neoplasms; Sequence Analysis, RNA; Tumor Microenvironment | 2022 |
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.
Topics: Acetylation; Acetylglucosamine; Animals; Antigens, Neoplasm; Carrier Proteins; Cell Line, Tumor; Datasets as Topic; Disease Progression; Female; Gene Expression Profiling; Glycolysis; HEK293 Cells; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Membrane Proteins; Mice; N-Acetylglucosaminyltransferases; Neoplasm Grading; Neoplasm Staging; Neoplasms; Protein Processing, Post-Translational; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tissue Array Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Female; Humans; MCF-7 Cells; Mice; Neoplasms; Polyethylene Glycols; Polymers; Prodrugs; Rats; Rats, Sprague-Dawley; Tumor Burden | 2017 |
Measuring O-GlcNAc cleavage by OGA and cell lysates on a peptide microarray.
Topics: Acetylglucosamine; beta-N-Acetylhexosaminidases; Caco-2 Cells; HT29 Cells; Humans; MCF-7 Cells; Microarray Analysis; Neoplasms; Peptide Fragments; Protein Processing, Post-Translational; Signal Transduction | 2017 |
A Chemoenzymatic Histology Method for O-GlcNAc Detection.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; Brain; Brain Chemistry; Histological Techniques; Humans; Mice; Neoplasms; Organ Specificity; Tissue Distribution | 2017 |
Topics: Acetylglucosamine; Adult; Aged; Drug Resistance, Multiple; Female; Humans; Male; Middle Aged; Neoplasms; Novobiocin; Sepsis; Staphylococcus hominis; Trehalose | 2017 |
Topics: Acetylglucosamine; Animals; beta-Transducin Repeat-Containing Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Glycosylation; HEK293 Cells; HeLa Cells; Host Cell Factor C1; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; N-Acetylglucosaminyltransferases; Neoplasms; NF-E2-Related Factor 1; Nuclear Respiratory Factor 1; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Interaction Domains and Motifs; Protein Stability; Ubiquitin; Xenograft Model Antitumor Assays | 2018 |
PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene.
Topics: Acetylglucosamine; Animals; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cytokines; Endocytosis; Endoglin; Endosomes; Galactosyltransferases; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Lysosomes; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Polyethylene Glycols; Protein Domains; Single-Chain Antibodies; Swine; Tissue Distribution | 2019 |
Antiadhesive Nanosomes Facilitate Targeting of the Lysosomal GlcNAc Salvage Pathway through Derailed Cancer Endocytosis.
Topics: Acetylglucosamine; beta-Galactosidase; beta-N-Acetylhexosaminidases; Cell Proliferation; Endocytosis; Hep G2 Cells; Humans; Lysosomes; Metabolic Networks and Pathways; Molecular Structure; Neoplasms; Protein Transport | 2019 |
Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
Topics: Acetylglucosamine; Biosynthetic Pathways; Cell Line, Tumor; Energy Metabolism; Glycolysis; Glycosylation; Hexosamines; Humans; Neoplasms; Oncogene Proteins; Protein Processing, Post-Translational; Signal Transduction; Tumor Suppressor Proteins | 2014 |
A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
Topics: Acetylglucosamine; Agaricales; Carbohydrate Sequence; Cell Line, Tumor; Crystallography, X-Ray; Epitopes; Glycoconjugates; Glycosylation; Humans; Lectins; Molecular Sequence Data; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides; Polysaccharides; Protein Binding; Recombinant Proteins; Spectrometry, Fluorescence; Staining and Labeling; Thermodynamics; Up-Regulation | 2015 |
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence.
Topics: Acetylglucosamine; Cellular Senescence; DNA; DNA Repair; Epigenesis, Genetic; Genomic Instability; Glutamine; Glycolysis; Humans; MCF-7 Cells; Neoplasms; RNA Interference | 2016 |
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
Topics: Acetylgalactosamine; Acetylglucosamine; Acute-Phase Proteins; Aged; Biomarkers; Blood Proteins; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Female; Follow-Up Studies; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Mortality; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Polysaccharides; Proportional Hazards Models; Randomized Controlled Trials as Topic; Reproducibility of Results; Retrospective Studies; Risk | 2016 |
Glucosamine and N-acetyl glucosamine as new CEST MRI agents for molecular imaging of tumors.
Topics: Acetylglucosamine; Animals; Contrast Media; Female; Glucosamine; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Imaging; MCF-7 Cells; Mice, Inbred BALB C; Molecular Imaging; Neoplasms | 2016 |
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Topics: Acetylglucosamine; Galactosyltransferases; Glycoproteins; Humans; Lung Neoplasms; Neoplasms; Polysaccharides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.
Topics: Acetylglucosamine; AMP-Activated Protein Kinases; Animals; Cell Line; Glucose; Glycogen; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Protein Processing, Post-Translational | 2009 |
(1)H-MRS can detect aberrant glycosylation in tumour cells: a study of the HeLa cell line.
Topics: Acetylglucosamine; Antigens, Neoplasm; Cell Count; Fucose; Galactosamine; Glycosylation; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Protons; Time Factors | 2011 |
Phosphofructokinase 1 glycosylation regulates cell growth and metabolism.
Topics: Acetylglucosamine; Acylation; Adenosine Triphosphate; Animals; Cell Hypoxia; Cell Line; Cell Line, Tumor; Cell Proliferation; Glucose; Glycolysis; Glycosylation; Humans; Lactic Acid; Mice; Mice, Nude; N-Acetylglucosaminyltransferases; NADP; Neoplasms; Pentose Phosphate Pathway; Phosphofructokinase-1, Liver Type | 2012 |
Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.
Topics: Acetylglucosamine; Animals; Aorta; Chlorocebus aethiops; COS Cells; Endothelial Cells; Extracellular Matrix; Gene Expression Regulation, Enzymologic; Glucosamine; Glucose; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Inflammation; Isoenzymes; Models, Biological; Neoplasms; Uridine Diphosphate | 2013 |
Incorporation of C14 from labeled glucuronic acid and N-acetyl glucosamine into polysaccharide by a cell free preparation from mouse mast-cell tumor.
Topics: Acetylglucosamine; Animals; Dietary Carbohydrates; Glucosamine; Glucuronates; Glucuronic Acid; Mast Cells; Mice; Neoplasms; Neoplasms, Experimental; Polysaccharides | 1962 |
Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues.
Topics: Acetylglucosamine; Adenocarcinoma; Adenoma; Cell Differentiation; Gastric Mucosa; Humans; Immunohistochemistry; Lymphatic Metastasis; Mucin-6; Mucins; N-Acetylglucosaminyltransferases; Neoplasms; Oligosaccharides; Organ Specificity; Sialyl Lewis X Antigen; Stomach Neoplasms | 2003 |
The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated.
Topics: Acetylglucosamine; Animals; Cells, Cultured; Chlorocebus aethiops; CHO Cells; Chromatography, Affinity; COS Cells; Cricetinae; DNA Methylation; Electrophoretic Mobility Shift Assay; Genes, Tumor Suppressor; Glycoconjugates; Glycosylation; Kruppel-Like Transcription Factors; Neoplasms; Peptide Fragments; Protein Conformation; Transcription Factors; Trypsin; Wheat Germ Agglutinins | 2004 |
Mitochondria-rich normal, metaplastic, and neoplastic cells show overexpression of the epitope H recognized by the monoclonal antibody H.
Topics: Acetylglucosamine; Antibodies, Monoclonal; Antigens, Neoplasm; Biomarkers, Tumor; Epitopes; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Metaplasia; Mitochondria; Neoplasms; Oxyphil Cells | 2005 |
Isolation of an N-acetyl-D-glucosamine specific lectin from the rhizomes of Arundo donax with antiproliferative activity.
Topics: Acetylglucosamine; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Hydrogen-Ion Concentration; Lectins; Leukocytes, Mononuclear; Mitogens; Neoplasms; Phytotherapy; Poaceae; Rhizome | 2005 |
N-acetyl-D-glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response.
Topics: Acetylglucosamine; Antineoplastic Agents; Calixarenes; Glycoconjugates; Humans; Killer Cells, Natural; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Models, Molecular; Molecular Conformation; Neoplasms; T-Lymphocytes | 2007 |
Deacetylase activity of human tumor cells producing immunosuppressive aminosugars: its possible role in resistance to cell-mediated cytotoxicity.
Topics: Acetylglucosamine; Amidohydrolases; Cytotoxicity, Immunologic; Hexosamines; Humans; Immunosuppressive Agents; Killer Cells, Natural; Mycoplasma; Neoplasms; Substrate Specificity; Tumor Cells, Cultured | 1993 |
Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal.
Topics: Acetylglucosamine; Ammonium Chloride; Cathepsin D; Enzyme Activation; Enzyme Precursors; Humans; Lysosomes; Mannose; Neoplasm Proteins; Neoplasms; Phosphorylation; Tumor Cells, Cultured | 1997 |
Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biodegradation, Environmental; Chitin; Drug Delivery Systems; Female; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Microspheres; Muramidase; Neoplasms; Neoplasms, Experimental; Paclitaxel; Poloxamer; Rats; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Temperature; Time Factors; Tumor Cells, Cultured | 2002 |
Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: a proton NMR spectroscopy study.
Topics: Acetylglucosamine; Alanine; Bone Marrow Transplantation; Humans; Inflammation; Longitudinal Studies; Magnetic Resonance Spectroscopy; N-Acetylneuraminic Acid; Neoplasms; Sialic Acids; Time Factors | 1991 |
Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutinin.
Topics: Acetylglucosamine; Antigens, Neoplasm; Carcinoma; Cells, Cultured; Cytotoxicity, Immunologic; Epitopes; Glioma; Humans; Immunity, Cellular; Kidney Neoplasms; Killer Cells, Natural; Lectins; Macrophages; Melanoma; Monocytes; Neoplasms; Urinary Bladder Neoplasms; Wheat Germ Agglutinins | 1985 |